openPR Logo
Press release

Endocrinology Drugs Market - Positive long-term growth outlook 2023

07-25-2017 11:00 AM CET | Health & Medicine

Press release from: Transparency Market Research

Endocrinology Drugs Market

Endocrinology Drugs Market

With the alarming increase in the prevalence of various hormone-related medical conditions, such as hypogonadism, diabetes, hyperthyroidism, and hypothyroidism, the global market for endocrinology drugs market has been witnessing a remarkable upsurge in its overall size and valuation. Since the incidence rate of diabetes is exceptionally high across the world, fueled by unhealthy diet and the reducing involvement of consumers in physical activities, the global market is likely to remain experiencing a high-paced rise in the years to come.

This exhaustive research report on the global market for endocrinology drugs offers a thorough assessment, emphasizing specifically on its past and current performance. The growth prospects of this market has also been studied in details in this report to predict its future status.

This report gives readers a comprehensive overview of the Endocrinology Drugs Market:
http://www.transparencymarketresearch.com/endocrinology-drugs-market.html

The rising number of cases of hypogonadism in men, triggered by diabetes and renal or heart disorders, is creating lucrative opportunities for market players. With the increasing intake of medications, the prospects for the market’s growth is likely to be boosted in the years to come. The increasing awareness among people pertaining to thyroid, diabetes, and other hormone-related disorders is also anticipated to drive this market in the future.

Due to the high prevalence of diabetes, the demand for diabetes drugs is higher than other products. Researchers expect this trend to remain so over the next few years, resulting in the high growth rate of the diabetes drug segment. The introduction of novel drug therapies and the presence of robust product pipelines in this market for the treatment of the both types of diabetes mellitus are likely to add significantly to the rise of this segment in the years to come.

In terms of the geography, the global endocrinology drugs market boasts of its presence across Asia Pacific, the Middle East and Africa, North America, Europe, and Latin America. Owing to the rising prevalence of endocrine diseases, North America has been dominating the worldwide endocrinology drugs market. Taking the augmenting usage of hormone replacement therapies and the favorable reimbursement policies by the governments in consideration, researchers anticipate the scenario to remain same over the next few years.

Get accurate market forecast and analysis on the Endocrinology Drugs Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1598

Asia Pacific, amongst other, is likely to report a high-paced growth in the years to come on the grounds of the rising prevalence of growth hormone deficiency and the imminent increase in the research and development activities in this region.

The surge in the cases of diabetes and endocrine gland associated cancer, such as end stage renal disorders, is also projected to have a positive impact on the Asia Pacific market for endocrinology drugs in the near future.

The leading producers of endocrinology drugs are Novo Nordisk, Merck, Sanofi, AstraZeneca, Eli Lily, and AbbVie. Some of the other prominent participants in this market are HanAll BioPharma, Bayer HealthCare Pharmaceuticals, Acerus Pharmaceuticals, BHV Pharma, Acrux DDS, Biocon, GSK, Hanmi Pharmaceutical, MannKind, Intrexon, ChipScreen Biosciences, Endo Pharmaceuticals, Takeda Pharmaceuticals, Oramed Pharmaceuticals, MacroGenics, Islet Sciences, KinDex Pharmaceuticals, VeroScience, Transition Therapeutics, and Gan and Lee Pharmaceuticals.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endocrinology Drugs Market - Positive long-term growth outlook 2023 here

News-ID: 639888 • Views: 226

More Releases from Transparency Market Research

Vascular Closure Devices Market Demands, Industry Size, Supply, Sales and Manufa …
Compliance with New EU-MDR May Lead to Shortage of Medical Devices amidst COVID-19 Crisis The European Parliament recently announced the postponement of the implementation of the new Medical Device Regulation (MDR) by a year, due to the unprecedented COVID-19 (coronavirus) outbreak. This will help medtech companies in the vascular closure devices market to stabilize their operations, owing to the debilitating consequences of the pandemic. This postponement is to come in practice
Laparoscopy Devices Market Offering Trends, Share, Size, Growth Until the End of …
Risk of Aerosolization of Coronavirus May Hamper Market Growth The laparoscopy devices market is projected to experience a slowdown during the COVID-19 outbreak, as minimally invasive surgical procedures carry the risk of aerosolization of blood-borne viruses. The SAGE (Scientific Advisory Group for Emergencies) and the EAES (European Association for Endoscopic Surgeons) have recommended patients to postpone their surgeries if not urgent due to the ongoing coronavirus outbreak. SAGE and EAES have laid
Clinical Trials Market Growth Opportunities Investment Analysis Report 2020-2030
Success of Clinical Trials for COVID-19 Vaccines Boosts Market Growth The coronavirus pandemic has brought research labs and healthcare institutions under great scrutiny for accelerating the clinical trials for COVID-19 vaccines. As such, the success in these clinical trials has led to global recognition of India for supplying several lack of free doses to Brazil, Bangladesh, Algeria, and South Africa. Countries such as Sri Lanka are following suit whilst creating incremental
Prefilled Syringes Market Share And Industry Trends, Forecasts Till and Million …
Prefilled Syringes Market Outlook 2031 The global prefilled syringes market was valued at US$ 13.6 Bn in 2021 The global market is projected to advance at a CAGR of 10.1% from 2022 to 2031 The global prefilled syringes market is anticipated to reach more than US$ 35.7 Bn by the end of 2031 Report Overview: https://www.transparencymarketresearch.com/prefilled-syringes-market.html Global Prefilled Syringes Market Introduction Prefilled syringe is a disposable syringe that already contains the substance to be injected.

All 5 Releases